Enhancing Rehabilitation After Stroke

Summary

Enhancing Rehabilitation After Stroke is a clinical trial^[1].

Key Facts

• Enhancing Rehabilitation After Stroke is in the country of United States^[2].
• Enhancing Rehabilitation After Stroke's instance of is recorded as clinical trial^[3].
• Enhancing Rehabilitation After Stroke's start time is recorded as +2009-03-31T00:00:00Z^[4].
• Enhancing Rehabilitation After Stroke's end time is recorded as +2013-08-31T00:00:00Z^[5].
• Enhancing Rehabilitation After Stroke's sponsor is recorded as Eunice Kennedy Shriver National Institute of Child Health and Human Development^[6].
• Enhancing Rehabilitation After Stroke's main subject is recorded as stroke^[7].
• Enhancing Rehabilitation After Stroke's number of participants is recorded as {'unit': '1', 'amount': '+200'}^[8].
• Enhancing Rehabilitation After Stroke's title is recorded as Donepezil to Promote Functional Recovery Post-stroke^[9].
• Enhancing Rehabilitation After Stroke's short name is recorded as Enhance^[10].
• Enhancing Rehabilitation After Stroke's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Enhancing Rehabilitation After Stroke's ClinicalTrials.gov ID is recorded as NCT00868010^[12].
• Enhancing Rehabilitation After Stroke's research intervention is recorded as donepezil^[13].
• Enhancing Rehabilitation After Stroke's clinical trial phase is recorded as phase III clinical trial^[14].
• Enhancing Rehabilitation After Stroke's research subject recruitment status is recorded as Coronavirus^[15].
• Enhancing Rehabilitation After Stroke's study type is recorded as interventional study^[16].